Karl Hess is the Managing Director at Outcome Capital, a position he has held since October 2020. Based in the United States, Karl also serves as a Consulting Advisor for Novo Holdings since January 2022. Prior to his current roles, he was the Interim President and CEO at Texas Health Aetna and the CEO at KALICO PARTNERS LLC. Karl's extensive experience includes senior positions at Welltok, Inc., Collain Healthcare, and WellDoc, Inc. He has also held roles at Leerink Partners, LLC, and PRTM. Karl's career began in research and development roles at Ambion, Inc. and UT Southwestern Medical Center.